Posted by Michael Wonder on 28 Mar 2018
Adjustment of application fees for CADTH pharmaceutical reviews
28 March 2018 - In February 2018, CADTH announced that beginning in April 2018 application fees for CADTH pharmaceutical reviews will be adjusted annually based on fluctuations in the Consumer Price Index.
CADTH has updated its Guidelines for Manufacturers on Application Fees for CADTH Pharmaceutical Reviews to reflect the adjusted fee schedule.
The new fee schedule is effective for all submissions or resubmissions received on or after 2 April 2018 and applies to CADTH’s Common Drug Review and CADTH’s pan-Canadian Oncology Drug Review programs.
